World's Best Scientists 2026 revealed!
Daniel J. George

Daniel J. George

Overview

Daniel J. George is affiliated with Duke University in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, with a particular focus on oncology and pulmonary medicine.

The scientist's primary fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their subfields of study highlight specific areas:

  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Oncology
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology

The main research topics covered by Daniel J. George include:

  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Cancer, Lipids, and Metabolism
  • Prostate Cancer Diagnosis and Treatment
  • Renal cell carcinoma treatment
  • Cancer Genomics and Diagnostics
  • Hormonal and reproductive studies

Daniel J. George has been published extensively in various journals. Their frequent publication venues are:

  • Journal of Clinical Oncology
  • Prostate Cancer and Prostatic Diseases
  • Cancer Epidemiology Biomarkers & Prevention
  • Annals of Oncology
  • Future Oncology

Among their recent papers are:

  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer, 2020, New England Journal of Medicine
  • Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial, 2022, Journal for ImmunoTherapy of Cancer
  • Novel therapies are changing treatment paradigms in metastatic prostate cancer, 2020, Journal of Hematology & Oncology
  • Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022, 2022, European Urology
  • LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types, 2021, Journal for ImmunoTherapy of Cancer

Frequent co-authors in their research collaborations include:

  • Andrew J. Armstrong
  • Tian Zhang
  • Susan Halabi
  • Neal D. Shore
  • Michael R. Harrison

Best Publications

  • Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    Charles J. Ryan;Matthew R. Smith;Johann S. De Bono;Arturo Molina

  • Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;M. Dror Michaelson;Bruce G. Redman;Gary R. Hudes

  • Sunitinib in Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Brian I. Rini;Brian I. Rini;Ronald M. Bukowski;Brendan D. Curti

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Prostate cancer. Clinical practice guidelines in oncology.

    James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

    Alain Ravaud;Robert J. Motzer;Hardev S. Pandha;Daniel J. George

  • Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

    Toni K. Choueiri;Susan Halabi;Ben L. Sanford;Olwen Hahn

  • Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate.

    Joel B. Nelson;Sean P. Hedican;Daniel J. George;A. H. Reddi

  • Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.

    Andrew J. Armstrong;Matthew S. Marengo;Sebastian Oltean;Sebastian Oltean;Gabor Kemeny

  • Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

    Giancarlo Agnelli;Daniel J. George;Ajay K. Kakkar;William Fisher

  • Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation : Effect of patient age and donor leukocyte infusions

    T.N. Small;E.B. Papadopoulos;F. Boulad;P. Black

  • Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma

    Brian I. Rini;M. Dror Michaelson;Jonathan E. Rosenberg;Ronald M. Bukowski

  • Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

    Andrew J Armstrong;Susan Halabi;Tim Eisen;Samuel Broderick

  • Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

    William Kevin Kelly;Susan Halabi;Michael Carducci;Daniel George

  • Prognostic Significance of Plasma Vascular Endothelial Growth Factor Levels in Patients with Hormone-refractory Prostate Cancer Treated on Cancer and Leukemia Group B 9480

    Daniel J. George;Susan Halabi;Timothy F. Shepard;Nicholas J. Vogelzang

  • Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.

    Toni K. Choueiri;Colin Hessel;Susan Halabi;Ben Sanford

  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

    Neal D. Shore;Fred Saad;Michael S. Cookson;Daniel J. George

  • Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma

    Leigh Ellis;Yan Pan;Gordon K. Smyth;Daniel J. George

  • Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

    Robert H. Vonderheide;Susan M. Domchek;Joachim L. Schultze;Daniel J. George

Frequent Co-Authors

Michael R. Harrison
Michael R. Harrison Duke University
Susan Halabi
Susan Halabi Duke University
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Eric J. Small
Eric J. Small University of California, San Francisco
Walter M. Stadler
Walter M. Stadler University of Chicago
Allan J. Pantuck
Allan J. Pantuck University of California, Los Angeles
Toni K. Choueiri
Toni K. Choueiri Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in studying Medicine in the USA, it's helpful to know about alternative online degrees and career pathways in healthcare. Many students begin by exploring nursing programs. For example, there are several absn programs that don't require teas, appealing to those wanting to become registered nurses without the added stress of entrance exams.

Another popular option is healthcare management. With flexible healthcare administration degree programs, students can develop leadership skills needed for careers in hospital or practice administration—often entirely online.

Nurses looking to advance their careers may consider specialized programs such as adn to np programs online. These bridge programs help registered nurses gain advanced practice skills and become nurse practitioners without starting over.

For those passionate about wellness, there are also excellent opportunities in nutrition. A online degree nutrition prepares students for careers in dietetics, public health, and wellness coaching. These online pathways offer flexibility while opening doors to diverse healthcare professions.

Best Scientists Citing Daniel J. George

Trending Scientists

Recently Published Articles